Showing results (411-420 of 528) with videos related to

Sort By:
Pageof 53
Cancer|October 15, 2008
Proceedings of the international consensus conference on breast cancer risk, genetics, & risk management, April, 2007Gordon F Schwartz, Kevin S Hughes, Henry T Lynch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteinsJ B Lawrence, C A Conover, T C Haddad, et al.
Breast Cancer Research and Treatment|September 24, 2009
Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasiaMarta Santisteban, Carol Reynolds, Emily G Barr Fritcher, et al.
Genes, Chromosomes & Cancer|July 6, 2004
ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriersCamilo Adem, Cheryl L Soderberg, Kari Hafner, et al.
Annals of Internal Medicine|June 20, 1998
Increased risk for cancer in patients with the Peutz-Jeghers syndromeL A Boardman, S N Thibodeau, D J Schaid, et al.
Oncogene|February 22, 2007
Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19qB Tews, P Roerig, C Hartmann, et al.
Cancer Prevention Research (Philadelphia, Pa.)|January 7, 2011
Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancerFritcher Emily G Barr, Amy C Degnim, Lynn C Hartmann, et al.
Gynecologic Oncology|May 8, 2009
Polymorphisms in TCEAL7 and risk of epithelial ovarian cancerAbraham Peedicayil, Robert A Vierkant, Vijayalakshmi Shridhar, et al.
Cancer|May 1, 1994
Randomized trial of cyclophosphamide, methotrexate, and 5-fluorouracil with or without estrogenic recruitment in women with metastatic breast cancerJ N Ingle, J F Foley, J A Mailliard, et al.
Cancer|July 15, 1997
A randomized phase II trial of two dosage levels of letrozole as third-line hormonal therapy for women with metastatic breast carcinomaJ N Ingle, P A Johnson, V J Suman, et al.
Pageof 53